Don't Just Read the News, Understand It.
Published loading...Updated

Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors

Summary by Benzinga
MUTTENZ, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a Swiss-based life sciences company developing a next-generation, non-glucose based peritoneal dialysis (PD) solution, today announced the appointment of two highly accomplished executives to its Board of Directors: Rice Powell, former Chairman and CEO of Fresenius Medical Care, and Mark Hahn, Chief Financial Officer of Verona Pharma and a veteran biotech finance leader.…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Monday, June 23, 2025.
Sources are mostly out of (0)